Status:

UNKNOWN

EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names

Lead Sponsor:

Centre Hospitalier St Anne

Conditions:

Intractable Epilepsy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Neurophysiologic evaluation of disorders of consciousness (DOC) patients in intensive care unit include late auditory evoked potentials. It allows the physicians to record cerebral responses of patien...

Detailed Description

Late auditory evoked potentials (as P3 wave) are used in neurophysiology to assess the level of consciousness in DOC (disorder of consciousness) patients. The P3 wave, elicited by listening standard a...

Eligibility Criteria

Inclusion

  • Intractable focal epilepsy with undergoing pre-surgical evaluation
  • intracerebral electrodes implantation in auditory cortices, temporal lobe, superior temporal gyrus, limbic areas, frontal lobe
  • Given Consent to inclusion

Exclusion

  • Deafness
  • Pregnancy

Key Trial Info

Start Date :

September 9 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 9 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04810832

Start Date

September 9 2020

End Date

September 9 2023

Last Update

July 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

GHU Paris - Sainte Anne

Paris, France, 75014

EXPRESON-IN : Intracerebral Recordings of P3a Responses to Expressive Own-names | DecenTrialz